Skip to content
HIV Clinical Topics Logo
  • Home
  • Program
  • Travel Grants
  • Scientific committee
  • Speakers and chairs
  • Support
  • About the event
    • Practical Info
    • Accreditation
  • Previous Editions
    • 2021
    • 2020
      • Program
      • Scientific committee
      • Speakers
      • Format and Activities
      • Online Library
      • Practical Info
    • 2019
    • 2018
  • Home
  • Program
  • Travel Grants
  • Scientific committee
  • Speakers and chairs
  • Support
  • About the event
    • Practical Info
    • Accreditation
  • Previous Editions
    • 2021
    • 2020
      • Program
      • Scientific committee
      • Speakers
      • Format and Activities
      • Online Library
      • Practical Info
    • 2019
    • 2018
Request a travel GrantVíctor Camposo2021-04-20T13:06:44+00:00

REQUEST A TRAVEL GRANT

All fields are required

    First Name

    Last Name

    Age

    Email

    Please repeat your email

    Phone

    Institution

    Position

    If you selected "Other", please specify

    If you selected "Speciality Physician" or "Resident Medical Intern", please specify your speciality

    Average number of HIV patients treated per month, if applicable

    Years of dedication to the HIV field

    City

    Country

    Grant request

    Travel

    Accommodation

    Motivation

    CV

    Prior knowledge test

    Please, complete the following questionnaire about general HIV Clinical Topics.
    This test has a purely informative purpose for the organization of the event. Your answers will not be taken into account when reviewing your candidacy as an attendee and/or fellow.

    1. Regarding a two-drug regimen with dolutegravir + lamivudine in initial ART, which one is false?

    2. Which one is not considered as a major component of the strategies to reduce HIV transmission?:

    3. Which one is expected to constitute a silent liver epidemic among HIV-infected subjects in the upcoming years?

    4. Regarding PrEP use, which one is false?

    5. Regarding drug-drug interactions with ART, which one is false:

    6. Which one should you consider the most important unmet need in ART?

    I agree to the terms and conditions

    [recaptcha]

    © Copyright 2018 -2020 HIVClinicalTopics.com | Privacy policy
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    Page load link
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT
    Go to Top